¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"primary hypertension"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pregnancy-induced hypertension
    ÀӽŰíÇ÷¾Ð
  • pulmonary hypertension
    Æóµ¿¸Æ°íÇ÷¾Ð, ÇãÆÄµ¿¸Æ°íÇ÷¾Ð
  • renal hypertension
    ÄáÆÏ°íÇ÷¾Ð, ½ÅÀ强°íÇ÷¾Ð
  • renovascular hypertension
    ÄáÆÏÇ÷°ü°íÇ÷¾Ð, ½ÅÀåÇ÷°ü°íÇ÷¾Ð
  • stasis hypertension
    ¿ïÇ÷°íÇ÷¾Ð
  • secondary hypertension
    ÀÌÂ÷°íÇ÷¾Ð
  • sinusoidal hypertension
    ±¼Ç÷°ü°íÇ÷¾Ð
  • delayed primary suture
    Áö¿¬ÀÏÂ÷ºÀÇÕ
  • primary
    ÀÏÂ÷-, ¿ø¹ß-
  • primary action
    ÀÏÂ÷ÀÛ¿ë
  • primary affect hunger
    ÀÏÂ÷Á¤µ¿°¥¸Á, ÀÏÂ÷¾ÖÁ¤°¥¸Á
  • primary aldosteronism
    ¿ø¹ß¾Ëµµ½ºÅ×·ÐÁõ
  • primary amebic meningoencephalitis
    ¿ø¹ß¾Æ¸Þ¹Ù¼ö¸·³ú¿°
  • primary amenorrhea
    ¿ø¹ß¹«¿ù°æ
  • primary amnion
    ÀÏÂ÷¾ç¸·, ¿ø½Ã¾ç¸·
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • primary polydipsia
    ¿ø¹ß¼º´ÙÀ½Áõ, ÀÏÂ÷Àû´ÙÀ½Áõ, ¿ø¹ß¼º´ÙÀ½´Ù°¥Áõ, ÀÏÂ÷Àû´ÙÀ½´Ù°¥Áõ
  • spontaneous primary peritonitis
    ¿ø¹ßº¹¸·¿°, ÀÏÂ÷º¹¸·¿°, ¿ø¹ß¹è¸·¿°, ÀÏÂ÷¹è¸·¿°
  • primary stage
    Ãʱâ
  • primary suture
    ÀÏÂ÷ºÀÇÕ
  • occult primary tumor
    Àẹ¿ø¹ßÁ¾¾ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • rebound hypertension
    ¹Ýµ¿°íÇ÷¾Ð
  • red hypertension
    È«Á¶°íÇ÷¾Ð, ºÓÀº°íÇ÷¾Ð
  • renal hypertension
    ÄáÆÏ°íÇ÷¾Ð
  • renovascular hypertension
    ÄáÆÏÇ÷°ü°íÇ÷¾Ð
  • secondary hypertension
    ÀÌÂ÷°íÇ÷¾Ð
  • stasis hypertension
    ¿ïÇ÷°íÇ÷¾Ð
  • ocular hypertension indicator
    ¾È±¸°íÇ÷¾ÐÁöÇ¥
  • primary action
    ÀÏÂ÷ÀÛ¿ë, ÀÏÂ÷±â´É
  • primary amenorrhea
    ¿ø¹ß¹«¿ù°æ, ÀÏÂ÷¹«¿ù°æ
  • primary amnion
    ¿ø½Ã¾ç¸·, ÀÏÂ÷¾ç¸·
  • primary amyloidosis
    ¿ø¹ß¾Æ¹Ð·ÎÀ̵åÁõ
  • primary aqueous
    ¿ø¹æ¼ö, ÀÏÂ÷¹æ¼ö
  • primary olfactory receiving area
    ÀÏÂ÷Èİ¢¿µ¿ª
  • primary sensory area
    ÀÏÂ÷°¨°¢±¸¿ª
  • primary bronchus
    ÀÏÂ÷±â°üÁö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hypertension,malignant
    ¾Ç¼º(äÂàõ)
  • hypertension,portal
    ¹®¸Æ¼º(Ú¦Øæàõ)
  • portal hypertension
    ¹®¸Æ¾ÐÇ×ÁøÁõ(Ú¦Øæäâùñòäñø), ¹®¸Æ°íÇ÷¾Ð(¡­ÍÔúìäâ).
  • portal hypertension
    ¹®¸Æ¾ÐÇ×ÁøÁõ(Ú¦Øæäâùñòäñø), ¹®¸Æ°íÇ÷¾Ð(Ú¦ØæÍÔúìäâ)
  • portal hypertension
    ¹®¸Æ¾ÐÇ×ÁøÁõ
  • pulmonary hypertension
    Æóµ¿¸Æ°íÇ÷¾Ð, Æó°íÇ÷¾ÐÁõ.
  • pulmonary hypertension
    Æóµ¿¸Æ°íÇ÷¾Ð(øËÔÑØæÍÔúìäâ), Æó°íÇ÷¾ÐÁõ(øËÍÔúìäâñø)
  • red hypertension
    È«Á¶¼º °íÇ÷¾ÐÁõ(ûõðÍàõÍÔúìäâñø).
  • red hypertension
    È«Á¶¼º °íÇ÷¾ÐÁõ(ûõðÍàõÍÔúìäâñø)
  • renal hypertension
    ½Å¼º °íÇ÷¾Ð(ãìàõÍÔúìäâ).
  • renal hypertension
    ½Å¼º °íÇ÷¾Ð(¡­ÍÔúìäâ)
  • Ghon s primary complex
    °ï¿ø¹ßÁõÈıº.
  • amyloidosis primary
    ¿ø¹ß¼º(ê«Û¡àõ) ¾Æ¹Ð·ÎÀ̵åÁõ.
  • immune response, primary
    ÀÏÂ÷¸é¿ª¹ÝÀÀ
  • immunodeficiency syndrome, primary
    ÀÏÂ÷¼º ¸é¿ª°áÇÌ ÁõÈıº, ¿ø¹ß¼º ¸é¿ª°áÇÌ ÁõÈıº
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hypertension
    °íÇ÷¾Ð(Áõ)(ÍÔúìäâ)
  • hypertension cranienne ºÒ
    ³ú¾ÐÇ×Áø(Áõ).
  • hypertension paroxystique ºÒ
    ¹ßÀÛ¼º °íÇ÷¾Ð(Áõ)(Û¡íÂàõÍÔúìäâñø).
  • hypertension,benign nephrosclerosis
    ¾ç¼º ½Å°æÈ­Áõ
  • hypertension,essential
    º»Å¼º(Üâ÷¾àõ)
  • hypertension,malignant
    ¾Ç¼º(äÂàõ)
  • hypertension,portal
    ¹®¸Æ¼º(Ú¦Øæàõ)
  • intracranial hypertension
    µÎ°³³»°íÇ÷¾Ð (¡­ÍÔúìäâ).
  • juvenile hypertension
    ¿¬¼Ò¼º °íÇ÷¾Ð(Áõ).
  • kallikrein-kinin,renal hypertension
    ½Å¼º°íÇ÷¾Ð(½Å¼º ÍÔúìäâ)
  • labile hypertension
    ºÒ¾ÈÁ¤¼º °íÇ÷¾Ð (¡­ÍÔúìäâ).
  • low renin essential hypertension
    Àú·¹´Ñ¼º º»Å¼º °íÇ÷¾Ð(­àõÜâ÷¾àõÍÔúì äâ).
  • malignant hypertension
    ¾Ç¼º°íÇ÷¾ÐÁõ(ÊÙË­Ì´ËâÌ¡).
  • malignant hypertension
    ¾Ç¼º°íÇ÷¾ÐÁõ(¡­ÍÔúìäâñø).
  • nephrogenous hypertension
    ½Å¼º°íÇ÷¾Ð (~ÍÔúìäâ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Primary ovarian follicle
    ÀÏÂ÷³­Æ÷
    [¿¾ ¿ë¾î] ÀÏÂ÷³­Æ÷
  • Primary cephalic vein
    ÀÏÂ÷¸Ó¸®Á¤¸Æ
    [¿¾ ¿ë¾î] ÀÏÂ÷µÎÁ¤¸Æ
  • Primary capillary network
    ÀÏÂ÷¸ð¼¼Ç÷°ü±×¹°
    [¿¾ ¿ë¾î] ÀÏÂ÷¸ð¼¼Ç÷°ü¸Á
  • Primary abdominal implantation
    ÀÏÂ÷¹è¾ÈÂø»ó
    [¿¾ ¿ë¾î] ÀÏÂ÷Àûº¹ºÎÂø»ó
  • Primary bone
    ÀÏÂ÷»À
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ
  • Primary osteon
    ÀÏÂ÷»À´ÜÀ§
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¿ø
  • Primary bone development
    ÀÏÂ÷»À¹ß»ý
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¹ß»ý
  • Primary osteogenic bud
    ÀÏÂ÷»À¹ß»ý½Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¹ß»ý·Ú
  • Primary osteogenic bud
    ÀÏÂ÷»À¹ß»ý½Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñÇü¼º¾Æ
  • Primary ossification center
    ÀÏÂ÷»À¹ß»ýÁß½É
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñÈ­Áß½É
  • Primary ossification center [Diaphyseal ossification center]
    ÀÏÂ÷»À¹ß»ýÁ᫐ [»À¸öÅë¹ß»ýÁß½É]
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñÈ­Áß½É
  • Primary bone trabecula
    ÀÏÂ÷»ÀÀܱâµÕ
    [¿¾ ¿ë¾î] ÀÏÂ÷°ñ¼ÒÁÖ
  • Primary trilaminar cortex
    ÀÏÂ÷»ïÃþÆÇ°ÑÁú
    [¿¾ ¿ë¾î] ÀÏÂ÷»ïÃþÆÇÇÇÁú
  • Primary nodule
    ÀÏÂ÷¼ÒÀý
    [¿¾ ¿ë¾î] ÀÏÂ÷¼ÒÀý
  • Primary bud
    ÀÏÂ÷½Ï
    [¿¾ ¿ë¾î] ÀÏÂ÷·Ú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • primary fluor
    ÀÏÂ÷ Çü±¤Ã¼(ìéó­û«ÎÃô÷)
  • primary immune response
    ÀÏÂ÷ ¸é¿ª´ëÀÀ(ìéó­Øóæ¹Óßëë)
  • primary ionization
    ÀÏÂ÷(ìéó­) ÀÌ¿ÂÈ­(ûù)
  • primary isotope effect
    ÀÏÂ÷ µ¿À§¿ø¼Ò È¿°ú(ìéó­ÔÒêÈêªáÈüùÍý)
  • primary lysosome
    ÀÏÂ÷(ìéó­) ¶óÀ̼ÒÁ»
  • primary messenger
    ÀÏÂ÷ Àü·É(ìéó­îîÖµ)
  • primary metabolite
    ÀÏÂ÷ ´ë»ç¹°Áú(ìéó­ÓÛÞóÚªòõ)
  • primary oxaluria
    ¿ø¹ß¼º(ê«Û¡àõ) ¿Á»ì»ê´¢Áõ(Òãñø)
  • primary pigment
    ÀÏÂ÷ »ö¼Ò(ìéó­ßäáÈ)
  • primary plot
    ÀÏÂ÷(ìéó­) Ç÷Ô
  • primary prostaglandin
    ÀÏÂ÷(ìéó­) ÇÁ·Î½ºÅ¸±Û¶õµò
  • primary protein derivative
    ÀÏÂ÷ ´Ü¹éÁúÀ¯µµÃ¼
  • primary response
    ÀÏÂ÷ ´ëÀÀ(ìéó­Óßëë)
  • primary solvent
    ÀÏÂ÷ ¿ë¸Å(ìéó­éÁØÚ)
  • primary standard
    ÀÏÂ÷ Ç¥ÁØ(ìéó­øöñÞ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • primary ossification center
    ÀÏÂ÷°ñÈ­Áß½É
  • primary ray
    ÀÏÂ÷¼±
  • primary tuberculosis
    ÀÏÂ÷°áÇÙ(Áõ), Ãʱâ°áÇÙ(Áõ)
  • primary tumor
    ¿ù¹ßÁ¾¾ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PA panic attack; pantothenic acid; paralysis agitans; paranoia; passive aggressive; pathology; patient'...
PCC Pasteur Culture Collection; percutaneous cecostomy; pheochromocytoma; phosphate carrier compound; pl...
IPH idiopathic portal hypertension; idiopathic pulmonary hemosiderosis; idiopathic pulmonary hypertensio...
STOP Study of Hypertension in the Elderly [Sweden] or Swedish Trial in Old Patients with Hypertension; su...
FPPH familial primary pulmonary hypertension
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AHT Arterial Hypertension
BIH Benign Intracranial Hypertension
BH Borderline hypertension
BHS British Hypertension Society
CT-E PH Chronic thromboembolic pulmonary hypertension
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • C primary afferent nociceptor
    C ÀÏÂ÷ ±¸½É¼º Ä§ÇØ ¼ö¿ëü, C ÀÏÂ÷ ±¸½É¼º À¯ÇØ ¼ö¿ë±â
  • early primary closure
    Á¶±â 1Â÷ ºÀÇÕ
  • ensitization 1. administration of antigen to induce a primary immune response; priming; immunization. 2. exposure to allergen that results in the development of hypersensitivity. 3. the coating of erythrocytes with antibody so that they are subject to lys
    ³»¹ø
    ƯÈ÷ ¾È°Ë ¿¬ÀÇ.
  • myelinated primary afferent
    ÀÏÂ÷ À¯¼öÃÊ ±¸½É ½Å°æ
  • nociceptive primary afferent
    Ä§ÇØ ¼ö¿ë¼º ÀÏÂ÷ ±¸½É ½Å°æ, À¯ÇØ ¼ö¿ë¼º ÀÏÂ÷ ±¸½É ½Å°æ
  • non-nociceptive A delta C primary afferent
    ºñÄ§ÇØ ¼ö¿ë¼º A µ¨Å¸ C ÀÏÂ÷ ±¸½É ½Å°æ, ºñÀ¯ÇØ ¼ö¿ë¼º A µ¨Å¸ C ÀÏÂ÷ ±¸½É ½Å°æ
  • non-nociceptive myelinated primary afferent
    ºñÄ§ÇØ ¼ö¿ë¼º ÀÏÂ÷ ±¸½É ¼¶À¯, ºñÀ¯ÇØ ¼ö¿ë¼º ÀÏÂ÷ ±¸½É ¼¶À¯
  • primary
    ÀÏÂ÷¼º, ¿ø¹ß¼º, ¿ø¹ß¼ºÀÇ, ÀÏÂ÷, ÀÏÂ÷ÀÇ, ÀÏÂ÷¼ºÀÇ, Á¦ÀÏÀÇ, ÃʱâÀÇ, ¿ø¹ßÀÇ, ÁÖµÈ
    ¹ß»ýµÇ´Â ½Ã±âÀÇ ¼ø¼­¿¡ À־ óÀ½ÀÎ.
  • primary adaptation
    ÀÏÂ÷ ¼øÀÀ, ÀÏÂ÷¼º ¼øÀÀ
  • primary adrenocortical insuffciency
    ¿ø¹ß¼º ºÎ½Å ÇÇÁú ±â´É ºÎÀü
  • primary afferent axon
    ÀÏÂ÷ ±¸½É¼º Ãà»è
  • primary afferent cell body
    ÀÏÂ÷ ±¸½É¼º ¼¼Æ÷ü
  • primary afferent fiber
    ÀÏÂ÷ ±¸½É ¼¶À¯
  • primary afferent nociceptive transmitter
    ÀÏÂ÷ ±¸½É À¯ÇØ ¼ö¿ë¼º Àü´Þ ¹°Áú
  • primary afferent nociceptor input
    ÀÏÂ÷ ±¸½É¼º Ä§ÇØ¼ö¿ëü ÀÔ·Â, ÀÏÂ÷ ±¸½É¼º À¯Çؼö¿ë±â ÀÔ·Â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
secondary hypertension Arterial hypertension produced by a known cause, e.g., hyperthyroidism, kidney disease, etc., in contrast to primary hypertension that is of unknown cause.
(05 Mar 2000)
pulmonary hypertension <cardiology> Abnormally elevated blood pressure within the pulmonary circuit (pulmonary artery).
Pulmonary hypertension may be secondary to another disease process (VSD, ASD, severe COAD) or occur as a primary disease process known as primary pulmonary hypertension.
(27 Sep 1997)
hypertension <cardiology> Persistently high arterial blood pressure. Hypertension may have no known cause (essential or idiopathic hypertension) or be associated with other primary diseases (secondary hypertension).
This condition is considered a risk factor for the development of heart disease, peripheral vascular disease, stroke and kidney disease.
(29 Sep 1997)
hypertension, malignant Severe hypertension characterised by papilledema and necrosis of small arteries and arterioles. The diastolic pressure is generally greater than 130 mm hg.
(12 Dec 1998)
hypertension, portal Abnormally increased pressure in the portal venous system; frequently seen in cirrhosis of the liver and in other conditions which cause obstruction of the portal vein.
(12 Dec 1998)
hypertension, pulmonary High blood pressure in the pulmonary arteries. Normally, the pressure in the pulmonary arteries is low (compared to that in the aorta). Pulmonary hypertension can irrevocably damage the lungs. Pulmonary hypertension is made up of pulmonary for lung, hyper for high, and tension for blood pressure. (in french, the word for blood pressure is tension ).
(12 Dec 1998)
hypertension, renal Hypertension due to renal diseases, especially chronic parenchymal disease. Hypertension as a result of compression or obstruction of the renal artery or its branches is hypertension, renovascular.
(12 Dec 1998)
hypertension, renovascular Hypertension due to compression or obstruction of the renal artery or its branches.
(12 Dec 1998)
neonatal pulmonary venous hypertension <radiology> With cardiomegaly, hypoplastic left heart, critical aortic stenosis, cor triatriatum, pulmonary venous atresia, normal heart size, infradiaphragmatic TAPVR
(12 Dec 1998)
systemic venous hypertension Increased pressure in the veins ultimately leading to the right atrium nearly always due to disease of the right heart but occasionally due to blockade of one or both venae cavae.
(05 Mar 2000)
idiopathic hypertension Hypertension without known cause.
Synonym: idiopathic hypertension, primary hypertension.
(05 Mar 2000)
idiopathic pulmonary hypertension <chest medicine> A condition where there is increased blood pressure in the pulmonary arteries with otherwise normal heart and lungs.
The cause is unknown, but there is diffuse narrowing of the pulmonary arteries resulting in increased arteriolar pressures. Secondary heart failure ensues without correction of this problem. There is an increased incidence of this disease in females between the ages of 20 and 40 years. Treatment may include a heart and lung transplant in select cases.
(27 Sep 1997)
intracranial hypertension Increased pressure of the cerebrospinal fluid. If symmetrically distributed it may have few neurologic symptoms (e.g., pseudotumour cerebri), but if it is asymmetrical (as in hydrocephalus), neurological symptoms are often severe.
(12 Dec 1998)
ocular hypertension A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma.
(12 Dec 1998)
essential hypertension Hypertension without known cause.
Synonym: idiopathic hypertension, primary hypertension.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • primary colors
    ¿ø»ö(»¡°­,³ë¶û,ÆÄ¶û)
  • primary consumer
    Á¦1Â÷ ¼ÒºñÀÚ(ÃÊ½Ä µ¿¹°)
  • primary coolant
    (¿øÀÚ·ÎÀÇ) 1Â÷ ³Ã°¢¼ö )
  • primary education
    ÃÊµî ±³À°
  • primary election
    ¿¹ºñ ¼±°Å
  • primary group
    Á¦ ÀÏÂ÷ Áý´Ü(°¡Á¤,Ä£±¸ µî)
  • primary health worker
    (³óÃÌÀÇ) °£ÀÌ ÀÇ·á º¸Á¶¿ø !
  • primary industry
    1Â÷ »ê¾÷(³ó¸²,¼ö»ê)
  • primary meeting
    ¿¹¼± ´ëȸ;»çÀü ÇùÀÇȸ
  • primary planet
    Ç༺
  • primary producer
    Á¦1Â÷ »ý»êÀÚ(±¤ÇÕ¼º¿¡ ÀÇÇØ ¹«±â¹°¿¡¼­ À¯±â¹°À» »ý»êÇÏ´Â ½Ä¹°)
  • primary production
    1Â÷ »ý»ê(±¤ÇÕ¼º »ý¹°¿¡ ÀÇÇÑ À¯±â¹°ÀÇ »ý»ê)
  • primary products
    ³ó»ê¹°
  • primary root
    ÁÖ±Ù
  • primary school
    ±¹¹ÎÇб³;»ïÇгâ±ÞÀÇ ±¹¹Î Çб³
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á